# Top 50 Biotech Startup Investors in United States in October 2023

| Investor | Relevant Deals | Geography | Stage | Focus |
| --- | --- | --- | --- | --- |
| ARCH Venture Partners | 98 | United States, China, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Alexandria Venture Investments | 75 | United States, France, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| OrbiMed | 67 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| Innova Memphis | 63 | United States, Argentina, United Kingdom | Seed, Pre-Seed, Convertible Note | Health Care, Medical, Medical Device |
| New Enterprise Associates | 63 | United States, India, China | Series B, Series A, Series C | Software, Health Care, Biotechnology |
| 5AM Ventures | 61 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Atlas Venture | 60 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| MPM Capital | 60 | United States, Canada, Germany | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| Versant Ventures | 60 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Third Rock Ventures | 55 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Polaris Partners | 54 | United States, Singapore, Ireland | Series B, Series A, Series C | Biotechnology, Health Care, Medical |
| Canaan Partners | 50 | United States, Israel, India | Series A, Series B, Series C | Software, Biotechnology, Health Care |
| BioAdvance | 49 | United States, Canada | Seed, Series A | Biotechnology, Health Care, Medical |
| Khosla Ventures | 48 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Health Care, Artificial Intelligence |
| F-Prime Capital | 46 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical |
| RA Capital Management | 44 | United States, United Kingdom, China | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Novartis Venture Fund | 41 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Frazier Healthcare Partners | 40 | United States, Canada, Ireland | Series B, Series A, Post-IPO Equity | Biotechnology, Health Care, Therapeutics |
| Connecticut Innovations | 40 | United States, Israel, Canada | Series A, Seed | Health Care, Biotechnology, Software |
| DCVC | 38 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care |
| The Column Group | 37 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Fifty Years | 37 | United States, Germany, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Medical |
| Hatteras Venture Partners | 37 | United States, Canada | Series A, Series B | Biotechnology, Health Care, Medical |
| Andreessen Horowitz | 37 | United States, United Kingdom, Canada | Series A, Series B, Seed | Software, Information Technology, Internet |
| Lux Capital | 35 | United States, Canada, United Kingdom | Series A, Seed, Series B | Software, Health Care, Biotechnology |
| Boston Harbor Angels | 35 | United States, Canada, India | Angel, Seed, Series A | Biotechnology, Health Care, Medical Device |
| Northpond Ventures | 35 | United States, United Kingdom, Australia | Series A, Series B, Series C | Biotechnology, Health Care, Life Science |
| Amgen Ventures | 33 | United States, United Kingdom, Canada | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| KdT Ventures | 33 | United States, Israel, Germany | Seed, Series A, Series B | Biotechnology, Health Care, Medical |
| Sofinnova Investments | 33 | United States, France, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| Google Ventures | 33 | United States, United Kingdom, Canada | Series B, Series A, Seed | Software, Health Care, Biotechnology |
| Life Science Angels | 32 | United States, Israel, The Netherlands | Seed, Series A | Biotechnology, Health Care, Medical |
| Domain Associates | 32 | United States, Canada, Estonia | Series B, Series C, Series A | Biotechnology, Health Care, Medical |
| Dolby Family Ventures | 32 | United States, Austria, Israel | Series A, Seed, Series B | Biotechnology, Health Care, Therapeutics |
| Pfizer Venture Investments | 32 | United States, United Kingdom, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Wisconsin Investment Partners | 31 | United States, Canada, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical |
| Takeda Ventures | 31 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics |
| North Carolina Biotechnology Center | 30 | United States, United Kingdom | Debt Financing, Grant | Biotechnology, Health Care, Medical |
| Refactor Capital | 30 | United States, United Kingdom, New Zealand | Seed, Series A, Series B | Health Care, Biotechnology, Medical |
| Bay City Capital | 29 | United States, Canada, Denmark | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| HealthCare Ventures | 29 | United States, Australia, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| Casdin Capital | 29 | United States, France, China | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Vivo Capital | 29 | United States, China, Canada | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| SR One | 28 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Alumni Ventures | 28 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Information Technology, Health Care |
| Novo Holdings | 27 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Omega Funds | 27 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| St. Louis Arch Angels | 27 | United States, Argentina | Seed, Series A | Biotechnology, Health Care, Software |
| Founders Fund | 27 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Health Care, Internet |
| iSelect Fund | 27 | United States, Australia | Seed, Series A, Series B | Biotechnology, Health Care, Agriculture |

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co